Long-Acting Injectables: A New Solution for Nonadherence in Patients with Schizophrenia

Description

Medication adherence challenges are exacerbated in patients with chronic medical and mental health conditions, with nonadherence reaching as high as 90% in those with schizophrenia. Long-acting injectable antipsychotics have been introduced to contend with poor adherence and improve clinical and economic outcomes. Learn more about them and how to select the right one for your patients with schizophrenia.

Pharmacist Learning Objectives

At the completion of this application-based activity, participants will be able to:

  1. Describe the prevalence of medication nonadherence among patients with mental illness and the potential role of long-acting injectable (LAI) antipsychotics in improving adherence.
  2. Compare the currently available LAI antipsychotics.
  3. Discuss the clinical and economic advantages and disadvantages of LAI antipsychotics.
  4. Describe the role of pharmacists in ensuring medication adherence in patients using   LAI antipsychotics.
  5. Select the most appropriate LAI antipsychotic for a given patient case.
 
 
 
Speakers:
Susie
Susie Park, PHARMD
Associate Professor of Clinical Pharmacy
USC School of Pharmacy
 
Learning Level: Level 2
Track: Specialty Pharmacy, Clinical Patient Care and Services
Session Time Slot(s): 
Date: 
Friday, March 16
Time: 
10:00 AM - 11:30 AM
Room: 
Music City Center - Room 106A-C
ACPE Pharmacist: 0202-0000-18-062-L05-P
CEUs Pharmacist: 0.15
Activity Type:
Application-based